26 January, 2024
Trinity St. James’s Cancer Institute (TSJCI) is delighted to announce the second Call of its Cancer Research Stimulus Awards, a research funding scheme that will provide seed funding to foster and develop new research collaborations across the Cancer Institute. These awards have arisen from generous philanthropic donations totalling €120,000.
Objectives: The programme is designed to support short-term (up to 12 months) new, innovative research projects that will enhance the ability of TSJCI researchers to:
Scope and eligibility: The focus of the proposal must be aligned with at least one of TSJCI’s Research Themes: 1. Cancer Prevention; 2. Molecular and Precision Oncology; 3. Cancer Immunology; 4. Cancer Survivorship and Supportive Care. Research proposals must involve a new partnership* between a scientist/non-clinical researcher and a clinical researcher. Additional collaborators may be included as appropriate for your proposal. Public and patients’ participation in developing the proposal and in its execution is strongly encouraged. Importantly, you don’t have to have a track record in cancer research; rather, an excellent idea which you can deliver on.
[*If you have a great idea but are unsure of a suitable partner, Prof. Lorraine O’Driscoll lodrisc@tcd.ie and Dr. Patricia Doherty Patricia.Doherty@tcd.ie will be delighted to help find an appropriate match].
This Call is open to all in TCD and SJH (and affiliated hospitals) who are permanent members of staff or whose contracts would last for the duration of the project. Proposals will be accepted for projects that are challenging and innovative, giving rise to high impact future collaborative funding applications, publications, IP and/or clinical trials. Applications will be reviewed by a panel including external members and representatives from TSJCI, including cancer patient representation.
Funding limit: The budget requested should be appropriate to the scale and impact of the project proposed. The maximum funding that can be requested per proposal is €12,000.
Duration of the award: Up to 12 months from the start date of the award. Successful applicants must be in a position to start their projects by September 2024.
Reporting: Successfully applicants must engage with TSJCI Patient Representative Group (PRG) from month-3 of their project. Reporting with be in the form of (i) a podium presentation at TSJCI Research Day 2024 and (ii) a final written report, submitted within 3 months of the grant period and demonstrating evidence of the intended output e.g., a submitted grant application using the data generated as a result of this funding, etc. Funding not used for the purpose for which it was granted must be returned.
Application process: Please provide your application (min. font size 11, 2.5cm margins, single spaced) addressing the headings in the template provided below and adhering to word and page limits.
Any application exceeding these limits will not be reviewed. Please submit your application via e-mail to: ndhiarme@tcd.ie, no later than 5pm on Thursday, the 29th of February 2024.